H.R. 9661

Expedited Access to Biosimilars Act

Sponsor: Nicholas A. Langworthy · 2 cosponsors

Where it stands

Referred to the House Committee on Energy and Commerce. (Jul 14)

No roll-call votes yet.

No official summary yet.

Sec. 1. Short title

Sec. 2. Assessment of pharmacodynamics or efficacy in clinical studies required for licensure of biological products as biosimilar